621 related articles for article (PubMed ID: 29282029)
1. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
2. Prolonged high-glucose exposure decreased SREBP-1/FASN/ACC in Schwann cells of diabetic mice via blocking PI3K/Akt pathway.
Zhu L; Du W; Liu Y; Cheng M; Wang X; Zhang C; Lv X; Li F; Zhao S; Hao J
J Cell Biochem; 2019 Apr; 120(4):5777-5789. PubMed ID: 30362584
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid inhibits insulin-induced activation of sterol regulatory-element binding protein 1 and cyclooxygenase-2 expression through upregulation of SIRT1 in human colon epithelial cells.
Song NY; Na HK; Baek JH; Surh YJ
Biochem Pharmacol; 2014 Nov; 92(1):142-8. PubMed ID: 25199460
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
[TBL] [Abstract][Full Text] [Related]
6. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
7. Selective regulation of UGT1A1 and SREBP-1c mRNA expression by docosahexaenoic, eicosapentaenoic, and arachidonic acids.
Caputo M; Zirpoli H; Torino G; Tecce MF
J Cell Physiol; 2011 Jan; 226(1):187-93. PubMed ID: 20648548
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid increases the expression of oxidative stress-induced growth inhibitor 1 through the PI3K/Akt/Nrf2 signaling pathway in breast cancer cells.
Tsai CH; Shen YC; Chen HW; Liu KL; Chang JW; Chen PY; Lin CY; Yao HT; Li CC
Food Chem Toxicol; 2017 Oct; 108(Pt A):276-288. PubMed ID: 28807874
[TBL] [Abstract][Full Text] [Related]
9. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
10. Docosapentaenoic acid (22:5n-3) down-regulates the expression of genes involved in fat synthesis in liver cells.
Kaur G; Sinclair AJ; Cameron-Smith D; Barr DP; Molero-Navajas JC; Konstantopoulos N
Prostaglandins Leukot Essent Fatty Acids; 2011; 85(3-4):155-61. PubMed ID: 21807486
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
12. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells.
Yoon S; Lee MY; Park SW; Moon JS; Koh YK; Ahn YH; Park BW; Kim KS
J Biol Chem; 2007 Sep; 282(36):26122-31. PubMed ID: 17631500
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma.
Ezzeddini R; Taghikhani M; Somi MH; Samadi N; Rasaee MJ
Life Sci; 2019 May; 224():169-176. PubMed ID: 30914315
[TBL] [Abstract][Full Text] [Related]
15. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
[TBL] [Abstract][Full Text] [Related]
16. 3,5-Diiodo-l-thyronine induces SREBP-1 proteolytic cleavage block and apoptosis in human hepatoma (Hepg2) cells.
Rochira A; Damiano F; Marsigliante S; Gnoni GV; Siculella L
Biochim Biophys Acta; 2013 Dec; 1831(12):1679-89. PubMed ID: 23948263
[TBL] [Abstract][Full Text] [Related]
17. α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways.
Mason JK; Klaire S; Kharotia S; Wiggins AK; Thompson LU
Lipids Health Dis; 2015 Aug; 14():91. PubMed ID: 26282560
[TBL] [Abstract][Full Text] [Related]
18. Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer.
Qiu C; Dongol S; Lv QT; Gao X; Jiang J
Int J Gynecol Cancer; 2013 Nov; 23(9):1629-34. PubMed ID: 24105476
[TBL] [Abstract][Full Text] [Related]
19. Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter.
Jeon BN; Kim YS; Choi WI; Koh DI; Kim MK; Yoon JH; Kim MY; Hur B; Paik PD; Hur MW
J Lipid Res; 2012 Apr; 53(4):755-66. PubMed ID: 22331133
[TBL] [Abstract][Full Text] [Related]
20. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
